CClinicalTrials.gg
CompletedNCT02715973Updated Dec 6, 2018

Nutritional Assessment Tool and Nutritional Intervention in Childhood Chronic Liver Disease

An interventional study of Nutritional Supplement and Standard Nutritional Treatment in Chronic Liver Disease, sponsored by Institute of Liver and Biliary Sciences, India. Completed at 1 site in India. Open to participants aged 3 Months to 3 Years. Per ClinicalTrials.gov, last updated 2018-12-06.

Sponsored by Institute of Liver and Biliary Sciences, India · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
3 Months to 3 Years
Sex
All
01

Study summary

Children (Exclusively breast fed: 6mo - 3yrs, and who are not exclusively breast fed 3mo to 3 yrs) with infantile cholestasis syndrome will be randomized to either recieve indigenously prepared oral nutritional supplement (energy dense supplement appox. 2 kcal/mL, prepared from locally available, affordable, socially acceptable food items - milk, sugar, edible coconut oil, egg and custard powder as base) in addition to standard nutritional counseling by a trained dietician (Group A). The control group (Group B) in comparison will receive standard nutritional counseling from a trained dietician but will not receive any additional nutritional supplement. All the children will be followed up at 1 month, 3 months, 6 months, 9 months and 1 year after inclusion. Clinical, nutritional assessment and laboratory data will be collected at each visit. Additionally IL-6 levels will be done at each visit in children of both arms of the intervention group.

The outcomes of interest will be growth and improvement of nutritional status parameters, hepatic morbidity (ascites, gastrointestinal bleeding, encephalopathy, {SBP (Spontaneous Bacterial Peritonitis), HRS (Hepatorenal Syndrome), etc and outcome (improvement, death or Liver Transplantation}.

All children will receive individualized standard treatment for infantile cholestasis syndrome including vitamin supplements/endotherapy/ beta blockers/ prophylaxis for SBP (Spontaneous Bacterial Peritonitis)/cholangitis (to at risk children) and drug therapy wherever indicated (steroids/ copper chelation/ UDCA).

02

Conditions studied

  • Chronic Liver Disease

Browse trials for

03

In context

Liver Diseases

2,080 studies on the registry are indexed under Liver Diseases; 389 are open to participants now.

This study's enrollment of 40 is below the median of 50 across 1,322 interventional studies indexed under Liver Diseases.

Browse Liver Diseases studies →

Lead sponsor

Institute of Liver and Biliary Sciences, India is the lead sponsor of 296 studies on the registry; 84 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Months to 3 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Nutritional intervention in children with moderate and severe malnutrition as pr standard anthropometric measures children (Exclusively breast fed: 6mo - 3yrs, and who are not exclusively breast fed : 3mo to 3 yrs) with infantile cholestasis syndrome)
  2. Hindi/English speaking family

Exclusion criteria

Exclusion Criteria:

  1. Any metabolic or endocrinal diseases independently affecting nutritional status
  2. Refusal to give written informed consent to participate in the study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Nutritional Supplement

    Diet Counseling (Energy=200 kcal/kg/day, (present weight) protein =3-4 gm/kg/day) Nutritional supplement (Providing extra 40 kcal/kg/day)

    Dietary Supplement: Nutritional Supplement

  • Active comparator
    Standard nutritional treatment

    Diet counselling only (Energy=200 kcal/kg/day (present weight) protein =3-4 gm/kg/day). Standard nutritional treatment

    Dietary Supplement: Standard Nutritional Treatment

Interventions

  • Dietary supplementNutritional Supplement

    Energy dense supplement appox. 2 kcal/mL, prepared from locally available, affordable, socially acceptable food items - milk, sugar, edible coconut oil, egg and custard powder as base) in addition to standard nutritional counseling by a trained dietician as per the recommended daily allowance according to gender and age.

  • Dietary supplementStandard Nutritional Treatment

    Standard nutritional counseling by a trained dietician as per the recommended daily allowance according to gender and age

06

What researchers measure

Primary outcomes

  1. To study the effect of special fortified indigenous diet on growth,and outcome in children with infantile cholestasis syndrome

    Growth is a composite outcome defines as age and sex appropriate anthropometric measures- weight , height, mid arm circumference, triceps skin fold thickness, subscapular skin fold thickness.

    Time frame: 1 year

  2. To study the effect of special fortified indigenous diet on hepatic morbidity in children with infantile cholestasis syndrome

    hepatic morbidity is a composite outcome comprising of ascites, hepatic encephalopathy, spontaneous bacterial peritonitis, intercurrent infections, variceal bleed.

    Time frame: 1 year

  3. To study the effect of special fortified indigenous diet on outcome in children with infantile cholestasis syndrome

    Outcome is defined as survival with native liver, death or liver transplantation

    Time frame: 1 year

Secondary outcomes

  1. To study the levels of IL-6 before & after nutritional therapy in malnourished children with Chronic Liver Disease

    Time frame: 1 year

07

Study locations

1 site
  • Institute of liver and Biliary Sciences
    New Delhi, Delhi 110070, India
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 6, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02715973
Lead sponsor
Institute of Liver and Biliary Sciences, India
Responsible party
Sponsor
First posted
Mar 22, 2016
Start date
Jan 1, 2016
Primary completion
Oct 31, 2017
Completion
Oct 31, 2017
Last update
Dec 6, 2018

Study contacts

Dr Seema Alam, MD
study director · Institute of Liver and Biliary Sciences

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion